NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: results from an open-label, phase II study

ESMO Gastrointestinal Oncology · Elsevier

Аннотация

Publication date: September 2026 Source: ESMO Gastrointestinal Oncology, Volume 13, Part B Author(s): M. Ueno, K. Ikezawa, Y. Komatsu, H. Nagano, T. Hisano, T. Terashima, K. Nio, C. Morizane, S. Shimizu, M. Ozaka, H. Ohyama, T. Otsuru, K. Sudo, N. Mizuno, C. Daniel, L. Martín-Fernández, N. Amellal, K. Bernard, M. Sasaki

Читать у издателя →

Похожие статьи